These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. The role of current product release criteria for identification of human islet preparations suitable for clinical transplantation. Eckhard M; Brandhorst D; Winter D; Jaeger C; Jahr H; Bretzel RG; Brendel MD Transplant Proc; 2004 Jun; 36(5):1528-31. PubMed ID: 15251377 [TBL] [Abstract][Full Text] [Related]
28. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 4: Pre-clinical efficacy and complication data required to justify a clinical trial. Cooper DK; Casu A Xenotransplantation; 2009; 16(4):229-38. PubMed ID: 19799763 [TBL] [Abstract][Full Text] [Related]
29. Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience. Hirshberg B; Rother KI; Digon BJ; Lee J; Gaglia JL; Hines K; Read EJ; Chang R; Wood BJ; Harlan DM Diabetes Care; 2003 Dec; 26(12):3288-95. PubMed ID: 14633816 [TBL] [Abstract][Full Text] [Related]
30. [Islet transplantation in type I diabetes mellitus]. Lehmann R; Pavlicek V; Spinas GA; Weber M Ther Umsch; 2005 Jul; 62(7):481-6. PubMed ID: 16075955 [TBL] [Abstract][Full Text] [Related]
31. [Islet cell and pancreas transplantation in diabetes: status 1996]. Bretzel RG Ther Umsch; 1996 Dec; 53(12):889-901. PubMed ID: 9036567 [TBL] [Abstract][Full Text] [Related]
32. Intrahepatic transplanted islets in humans secrete insulin in a coordinate pulsatile manner directly into the liver. Meier JJ; Hong-McAtee I; Galasso R; Veldhuis JD; Moran A; Hering BJ; Butler PC Diabetes; 2006 Aug; 55(8):2324-32. PubMed ID: 16873697 [TBL] [Abstract][Full Text] [Related]